IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier. The gene discussed is IKBKB; the disease is experimental autoimmune encephalomyelitis.